Board Meeting Details
The Board of Directors meeting was held on November 11, 2026, at the company's registered office. The meeting commenced at 4:30 PM and concluded at 6:30 PM.
Financial Results Approval
The Board considered and approved the unaudited financial results for the half year ended September 30, 2026, together with the Limited Review Report issued by the statutory auditors, M/s. Krishaan & Co.
Financial Performance Highlights (H1 FY26 vs H2 FY25 vs H1 FY25)
- Revenue from Operations: ₹3,768.91 lakh (H1 FY26) vs ₹2,777.68 lakh (H2 FY25) vs ₹3,400.91 lakh (H1 FY25)
- Other Income: ₹33.66 lakh (H1 FY26) vs ₹39.31 lakh (H2 FY25) vs ₹7.90 lakh (H1 FY25)
- Total Income: ₹3,802.57 lakh (H1 FY26) vs ₹2,816.98 lakh (H2 FY25) vs ₹3,408.81 lakh (H1 FY25)
- Profit Before Tax: ₹85.77 lakh (H1 FY26) vs ₹(4.65) lakh (H2 FY25) vs ₹111.99 lakh (H1 FY25)
- Total Tax Expense: ₹28.02 lakh (H1 FY26) vs ₹(13.38) lakh (H2 FY25) vs ₹19.83 lakh (H1 FY25)
- Profit After Tax: ₹57.75 lakh (H1 FY26) vs ₹8.74 lakh (H2 FY25) vs ₹92.15 lakh (H1 FY25)
Earnings Per Share (EPS)
- Basic EPS: ₹0.28 (H1 FY26) vs ₹0.04 (H2 FY25) vs ₹0.45 (H1 FY25)
- Diluted EPS: ₹0.28 (H1 FY26) vs ₹0.04 (H2 FY25) vs ₹0.45 (H1 FY25)
Capital Structure
- Paid-up Equity Share Capital: ₹2,037.80 lakh (20,378,000 shares of ₹10 each)
- No change in share capital during the period.
Balance Sheet Position (as of September 30, 2026 vs March 31, 2026)
- Total Assets/Liabilities: ₹9,441.88 lakh vs ₹8,417.94 lakh
- Shareholders' Funds: ₹4,397.01 lakh vs ₹4,339.21 lakh
- Share Capital: ₹2,037.80 lakh (unchanged)
- Reserves and Surplus: ₹2,359.21 lakh vs ₹2,301.46 lakh
- Non-current Liabilities: ₹699.19 lakh vs ₹424.93 lakh
- Long-term borrowings: ₹386.27 lakh vs ₹165.55 lakh
- Other Long-term Liabilities: ₹234.37 lakh vs ₹187.18 lakh
- Long-term provisions: ₹78.55 lakh vs ₹72.19 lakh
- Current Liabilities: ₹4,345.68 lakh vs ₹3,653.74 lakh
- Short-term borrowings: ₹1,244.43 lakh vs ₹1,246.99 lakh
- Trade payables: ₹3,075.85 lakh vs ₹2,355.77 lakh
- Micro and small enterprises: ₹1,553.72 lakh vs ₹1,221.18 lakh
- Other creditors: ₹1,522.13 lakh vs ₹1,134.64 lakh
- Other current liabilities: ₹25.40 lakh vs ₹50.98 lakh
Asset Position (as of September 30, 2026 vs March 31, 2026)
- Non-current Assets: ₹598.96 lakh vs ₹511.51 lakh
- Property, Plant and Equipment: ₹535.25 lakh vs ₹493.59 lakh
- Intangible assets: ₹1.07 lakh vs ₹1.34 lakh
- Long-term loans and advances: ₹71.51 lakh vs ₹44.71 lakh
- Deferred Tax Asset (Net): ₹(8.87) lakh vs ₹(28.13) lakh
- Current Assets: ₹8,842.92 lakh vs ₹7,906.42 lakh
- Inventories: ₹2,812.25 lakh vs ₹2,208.50 lakh
- Trade Receivables: ₹5,012.22 lakh vs ₹4,716.40 lakh
- Cash and Cash equivalents: ₹2.53 lakh vs ₹4.45 lakh
- Short-term loans and advances: ₹1,015.92 lakh vs ₹980.07 lakh
Cash Flow Statement (H1 FY26 vs FY25)
- Net cash used in operating activities: ₹(149.87) lakh vs ₹(205.57) lakh (FY25)
- Net cash used in investing activities: ₹(70.22) lakh vs ₹(108.43) lakh (FY25)
- Net cash from financing activities: ₹218.16 lakh vs ₹276.53 lakh (FY25)
- Net decrease in cash: ₹(1.92) lakh vs ₹(37.47) lakh (FY25)
- Cash equivalents at end: ₹2.53 lakh vs ₹4.45 lakh (FY25)
IPO Proceeds Utilization
- The company raised ₹1,986.90 lakh through public issue (allotment date: September 20, 2024)
- Utilization as of September 30, 2026:
- Prepayment/repayment of borrowings: ₹494.00 lakh (100% utilized)
- Working capital requirements: ₹1,186.00 lakh (100% utilized)
- General corporate purposes: ₹108.21 lakh (100% utilized)
- Issue expenses: ₹198.69 lakh (100% utilized)
- No deviations or variations in utilization of IPO proceeds
- The statement was reviewed by the Audit Committee and taken on record by the Board
Auditor Review
- M/s. Krishaan & Co. (FRN: 001453S) carried out a limited review of the financial results
- The auditors issued an unmodified review report dated November 11, 2026
- Nothing came to their attention that causes them to believe the statement contains material misstatement
Documents Submitted
- Annexure-A: Unaudited financial results
- Annexure-B: Statement on deviation/variation of IPO funds (no deviation)
- Annexure-C: Utilization certificate for IPO proceeds from auditors